A detailed history of Wesbanco Bank Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Wesbanco Bank Inc holds 51,800 shares of ACAD stock, worth $884,226. This represents 0.03% of its overall portfolio holdings.

Number of Shares
51,800
Previous 51,800 -0.0%
Holding current value
$884,226
Previous $841,000 5.23%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$14.62 - $18.42 $365,500 - $460,500
25,000 Added 93.28%
51,800 $841,000
Q1 2024

Apr 23, 2024

BUY
$17.79 - $30.86 $476,772 - $827,048
26,800 New
26,800 $495,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Wesbanco Bank Inc Portfolio

Follow Wesbanco Bank Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.